Skip to content

Attention Bias Modification Treatment for Children With Social Anxiety

Attention Bias Modification Treatment for Children With Social Anxiety

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01397032
Enrollment
67
Registered
2011-07-19
Start date
2011-04-30
Completion date
2014-08-31
Last updated
2015-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Social Phobia

Keywords

attention bias modification treatment, cognitive bias modification, attention training, social anxiety

Brief summary

Children with social anxiety will be randomly assigned to either Attention Bias Modification Treatment (ABMT) designed to direct attention away from threat or a placebo control condition not designed to change attention patterns. Outcome measures will be depression and social anxiety symptoms as measured by gold standard questionnaires as well as diagnosis of social phobia disorder and symptom counts derived from structured clinical interviews with children and their parents. We expect to see significant reduction in social anxiety symptoms in the Attention Bias Modification Treatment (ABMT) group relative to the placebo control group.

Interventions

Behavioral: Attention Bias Modification Treatment (ABMT) Attention training using a computerized spatial attention task (dot-probe) modified to alter threat-related attention patterns.

Attention training using a computerized spatial attention task (dot-probe) not intended to alter threat-related attention patterns.

Sponsors

Tel Aviv University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
7 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* children suffering from social anxiety

Exclusion criteria

* Pharmacological or Psychological treatment

Design outcomes

Primary

MeasureTime frameDescription
Anxiety Disorders Interview Schedule for DSM-IV (ADIS)expected average time frame of 6 weeks. Participants will be assessed before and after the administriation of the training/control protocols.The ADIS is a semi-structured interview assessing anxiety, mood and externalizing disorders in children according to DSM-IV criteria.

Secondary

MeasureTime frameDescription
Social Phobia and Anxiety Inventory for Children (SPAI-C) and for Parents (SPAI-c-p)expected average time frame of 6 weeks. Participants will be assessed before and after the administriation of the training/control protocols.The SPAI is a 26-item self and parent-report instrument designed to assess social anxiety in children and adolescents. Items assess a range of potentially anxiety-producing situations.

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026